Shockwave Medical, Inc.SWAV

時価総額

PER

心血管向け医療機器の大手。IVLカテーテル（C2+、M5+、S4）を展開。2022年8月にC2+でMDR承認、2023年10月にM5+・S4で承認を取得。2023年純利益1億4730万ドル、2022年2億1600万ドルを計上。米国・欧州・日本を含む55か国超で展開。

	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	139	50	89	157	328
Short-term investments	56	152	112	148	662
Accounts receivable, net	7	12	37	71	115
Inventory	12	30	43	75	108
Prepaid expenses and other current assets	2	2	5	8	13
Total current assets	217	246	286	459	1,225
Operating lease right-of-use assets	9	8	27	32	30
Property and equipment, net	5	16	24	48	69
Equity method investment	-	-	6	4	2
Intangible assets, net	-	-	-	-	93
Goodwill	-	-	-	-	40
Deferred tax assets	-	-	-	98	99
Other assets	2	2	2	5	9
TOTAL ASSETS	232	272	346	646	1,567
Accounts payable	3	1	4	7	9
Accrued liabilities	14	20	41	55	92
Lease liability, current portion	1	1	2	1	4
Total current liabilities	24	26	52	63	104
Lease liability, noncurrent portion	8	7	28	35	35
Convertible Debt, Noncurrent	-	-	-	-	732
Debt, noncurrent portion	7	13	12	24	-
Contract with Customer, Liability, Noncurrent	-	-	-	12	12
Deferred tax liabilities	-	-	-	-	4
Long-term income tax liability	-	-	-	-	2
Other liabilities	-	-	-	-	9
TOTAL LIABILITIES	39	46	104	135	898
Common Stock, Value, Issued	0	0	0	0	0
Additional paid-in capital	371	469	495	549	558
Accumulated other comprehensive income (loss)	0	0	-0	-1	0
Retained earnings (accumulated deficit)	-178	-244	-253	-37	110
TOTAL STOCKHOLDERS’ EQUITY	193	226	242	511	669
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	232	272	346	646	1,567